Market Overview:
The global osteoarthritis pain market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of osteoarthritis, rising geriatric population, and technological advancements in the field of pain management. The global osteoarthritis pain market is segmented on the basis of type, application, and region. On the basis of type, it is divided into oral and non-oral segments. Oral segment dominates the market owing to its high adoption rate as compared to other treatment modalities such as injections or topical therapies. By application, hospital segment dominates the market due to increasing number of surgeries being performed for treating various orthopedic disorders including osteoarthritis.
Product Definition:
Osteoarthritis pain is a type of joint pain that is caused by osteoarthritis, which is a condition that results from the wearing down of the cartilage that covers and cushions the ends of bones in a joint. Over time, this can cause pain, stiffness, and swelling in the affected joint. Osteoarthritis pain can vary significantly from person to person, and may be constant or come and go. It is important to manage osteoarthritis pain effectively so that you can continue participating in activities you enjoy and maintain your quality of life.
Oral:
Osteoarthritis (OA) is a chronic degenerative joint disease of the knee or hip. It's the most common form of arthritis affecting around 10-15 million people in U.S and Europe. The condition is more commonly seen in geriatric population aged over 65 years, although it can occur at any age.
Non-Oral:
Non-oral (intravenous) medications are used to treat pain caused by osteoarthritis. The most commonly used non-oral drug classes include the following: Nonsteroidal Antiinflammatory Drugs (NSAIDs), Opioids, Acetaminophen/Paracetamol, and Local Anesthetics.
The global non-oral and its usage in osteoarthritis pain market was valued at USD 6.1 billion in 2016.
Application Insights:
The other application segment dominated the global osteoarthritis pain market in 2017, accounting for a share of over 60.0%. The increasing prevalence of joint disorders and growing geriatric population are some of the major factors driving this segment. According to a study published by the Centers for Disease Control and Prevention (CDC), around 54 million adults aged between 18 to 64 years have arthritis or chronic joint conditions. Furthermore, as per another study conducted by researchers at Stanford University School of Medicine, it is estimated that around 56% women and 43% men aged above 50 years suffer from osteoarthritis pain every year in U.S., with an annual incidence rate of over 2 million cases among females and 1 million among males in America alone.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large geriatric population base and increased healthcare expenditure are key factors responsible for its growth. In addition, favorable reimbursement policies for the treatment of osteoarthritis pain and high awareness levels about OA treatments are also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period owing to increasing disposable income levels, rising health consciousness among people aged 25 years and above, growing access to health insurance schemes, improving healthcare facilities in rural areas as well as rapid urbanization & development in emerging economies such as China & India.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the osteoarthritis pain market growth during the forecast period.
- Rising awareness about osteoarthritis: There is a growing awareness about osteoarthritis among people, which is resulting in an increase in the number of people seeking treatment for it. This is likely to boost the demand for osteoarthritis pain treatments and products in the coming years.
- Technological advancements: The development of new technologies and therapies for treating osteoarthritis pain will create opportunities for market growth during the forecast period.
- Growing prevalence of obesity: Obesity has been identified as one of the major risk factors for developing arthritis, thus leading to an increase in its prevalence worldwide. This will result in an increased demand for treatments and products catering to obese patients with arthritis, thereby driving market growth over the forecast period. 5) Rising healthcare expenditure: With rising income levels, there has been a corresponding rise in healthcare expenditure around thw world In particular, there has been a significant increase In spending on chronic diseases such as arthritis Consequently, this Is likely to fuel ths Osteoporosis Pain Market’sgrowth overtheforecastperiod
Scope Of The Report
Report Attributes
Report Details
Report Title
Osteoarthritis Pain Market Research Report
By Type
Oral, Non-Oral
By Application
Hospital, Pharmacy, Other
By Companies
Abbott Laboratories, Johnson & Johnson, Novartis International, Pfizer, AbbVie, Abiogen Pharma, Afferent Pharmaceuticals, Astellas Pharma, BioDelivery Sciences International, Crystal Genomics, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Osteoarthritis Pain Market Report Segments:
The global Osteoarthritis Pain market is segmented on the basis of:
Types
Oral, Non-Oral
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Johnson & Johnson
- Novartis International
- Pfizer
- AbbVie
- Abiogen Pharma
- Afferent Pharmaceuticals
- Astellas Pharma
- BioDelivery Sciences International
- Crystal Genomics
- Abbott Laboratories
Highlights of The Osteoarthritis Pain Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Non-Oral
- By Application:
- Hospital
- Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Osteoarthritis Pain Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Osteoarthritis is a condition that affects the cartilage in the joints. Cartilage is a type of tissue that helps to protect and cushion bones. Over time, osteoarthritis can cause pain and stiffness in the joints.
Some of the major players in the osteoarthritis pain market are Abbott Laboratories, Johnson & Johnson, Novartis International, Pfizer, AbbVie, Abiogen Pharma, Afferent Pharmaceuticals, Astellas Pharma, BioDelivery Sciences International, Crystal Genomics, Abbott Laboratories.
The osteoarthritis pain market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Osteoarthritis Pain Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Osteoarthritis Pain Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Osteoarthritis Pain Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Osteoarthritis Pain Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Osteoarthritis Pain Market Size & Forecast, 2018-2028
4.5.1 Osteoarthritis Pain Market Size and Y-o-Y Growth
4.5.2 Osteoarthritis Pain Market Absolute $ Opportunity
Chapter 5 Global Osteoarthritis Pain Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Osteoarthritis Pain Market Size Forecast by Type
5.2.1 Oral
5.2.2 Non-Oral
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Osteoarthritis Pain Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Osteoarthritis Pain Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Osteoarthritis Pain Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Osteoarthritis Pain Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Osteoarthritis Pain Analysis and Forecast
9.1 Introduction
9.2 North America Osteoarthritis Pain Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Osteoarthritis Pain Market Size Forecast by Type
9.6.1 Oral
9.6.2 Non-Oral
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Osteoarthritis Pain Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Osteoarthritis Pain Analysis and Forecast
10.1 Introduction
10.2 Europe Osteoarthritis Pain Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Osteoarthritis Pain Market Size Forecast by Type
10.6.1 Oral
10.6.2 Non-Oral
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Osteoarthritis Pain Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Osteoarthritis Pain Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Osteoarthritis Pain Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Osteoarthritis Pain Market Size Forecast by Type
11.6.1 Oral
11.6.2 Non-Oral
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Osteoarthritis Pain Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Osteoarthritis Pain Analysis and Forecast
12.1 Introduction
12.2 Latin America Osteoarthritis Pain Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Osteoarthritis Pain Market Size Forecast by Type
12.6.1 Oral
12.6.2 Non-Oral
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Osteoarthritis Pain Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Osteoarthritis Pain Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Osteoarthritis Pain Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Osteoarthritis Pain Market Size Forecast by Type
13.6.1 Oral
13.6.2 Non-Oral
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Osteoarthritis Pain Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Osteoarthritis Pain Market: Competitive Dashboard
14.2 Global Osteoarthritis Pain Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Johnson & Johnson
14.3.3 Novartis International
14.3.4 Pfizer
14.3.5 AbbVie
14.3.6 Abiogen Pharma
14.3.7 Afferent Pharmaceuticals
14.3.8 Astellas Pharma
14.3.9 BioDelivery Sciences International
14.3.10 Crystal Genomics
14.3.11 Abbott Laboratories
